Literature DB >> 7600183

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide.

D R Howlett1, K H Jennings, D C Lee, M S Clark, F Brown, R Wetzel, S J Wood, P Camilleri, G W Roberts.   

Abstract

The behaviour of synthetic batches of beta-amyloid (beta A) 1-40 peptide in solution has been studied. The effects of beta A1-40 on a PC12 cell toxicity assay was dependent upon the time of preincubation of an aqueous solution of the peptide before application to the cells. Fibrillization of the beta A1-40, quantitatively assessed by the binding of Congo red to amyloid fibrils, also increased in a time dependent manner over the 168 h incubation period studied. The degree of Congo red binding, in the absence of any preincubation, differed between two synthetically distinct batches of the peptide. The rate of development of fibril formation during subsequent incubation also differed between the two batches and appeared to parallel the effects on cell viability. Infra-red spectroscopic analysis revealed beta-sheet formation for both batches and other more subtle conformational differences between the peptides. Electron microscope examination of the batches of beta A1-40 confirmed the difference in occurrence and development of fibrils. At high magnification, fibrils of both batches exhibited a helical structure. The results suggest that the development of neurotoxicity of beta A1-40 is related to the fibrillar state of the peptide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600183     DOI: 10.1006/neur.1995.0003

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  24 in total

1.  Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

Authors:  D R Howlett; A E Perry; F Godfrey; J E Swatton; K H Jennings; C Spitzfaden; H Wadsworth; S J Wood; R E Markwell
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

3.  Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.

Authors:  Yoko Furukawa-Hibi; Tursun Alkam; Atsumi Nitta; Akihiro Matsuyama; Hiroyuki Mizoguchi; Kazuhiko Suzuki; Saliha Moussaoui; Qian-Sheng Yu; Nigel H Greig; Taku Nagai; Kiyofumi Yamada
Journal:  Behav Brain Res       Date:  2011-07-27       Impact factor: 3.332

Review 4.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

Authors:  B Solomon; R Koppel; D Frankel; E Hanan-Aharon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide.

Authors:  R V Ward; K H Jennings; R Jepras; W Neville; D E Owen; J Hawkins; G Christie; J B Davis; A George; E H Karran; D R Howlett
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

8.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

9.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

10.  Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by Citrate.

Authors:  Yong Hoon Park; Young-Jin Kim; Il Hong Son; Hyun Duk Yang
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.